OptimizeRx Reports Fourth Quarter and Full Year 2017 Results; Q4 Net Revenue Up 75% to Record $4.0 Million
Summary
ROCHESTER, Mich., Feb. 27, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (OTCQB:OPRX), a leading provider of digital health messaging to the pharmaceutical industry, reported results for the fourth quarter and full year ended December 31, 2017.The increase was primarily due to revenue from OptimizeRx’s two core products of financial and brand messaging coupled with broader distribution with the company’s new channel partners.“Our record topline in Q4 and full year was driven by strong growth in our financial and brand messaging products,” said OptimizeRx CEO, William Febbo.“Also supporting our growth is the fact that our platform solves major pain points for healthcare providers by eliminating the need to manage and store physical drug samples, as well as spending time they don’t have with pharma sales representatives.The company’s cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and critical clinical information.
Classifications
AskAI Classifications
LabelsLinked Companies
